Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference244 articles.
1. The ERBB network: at last, cancer therapy meets systems biology;Yarden;Nat Rev Cancer.,2012
2. Should we be surprised at the paucity of response to EGFR inhibitors?;Gusterson;Lancet Oncol.,2009
3. Targeting epidermal growth factor receptor–are we missing the mark?;Dancey;Lancet.,2003
4. Acquired resistance to TKIs in solid tumours: learning from lung cancer;Camidge;Nat Rev Clin Oncol.,2014
5. Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas;Cortot;Eur Respir Rev.,2014
Cited by 142 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of a first-in-class protein degrader for the c-ros oncogene 1 (ROS1);Bioorganic Chemistry;2024-09
2. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29
3. Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response;International Journal of Molecular Sciences;2024-08-29
4. Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach;Biomacromolecules;2024-08-26
5. In vitro and in silico evaluation of 4'-hydroxy-[1,1'-biphenyl]-4-carbohydrazide Schiff base and oxadiazole derivatives targeting EGFR allosteric site;Chemical Papers;2024-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3